IP Library Granted Patent US 11,406,728
Granted Patent B2
US 11,406,728 · App. 17/066,985 · Granted Aug 9, 2022

Self-contained, portable, sanitization device and telemedicine station

Inventors: Mehdi Hatamian (Mission Viejo, CA); Paul Edalat (Newport Beach, CA)
Assignee: Vivera Pharmaceuticals Inc.
A61L2/18A61L2/24A61L2/28A61L2202/14A61L2202/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,728
App. No.
17/066,985
Granted
Aug 9, 2022
Kind
B2
Abstract

A sanitization device and telemedicine station (SDTS) may automatically detect and disinfect users as the users pass through the device. Sanitizing solution may be distributed throughout a disinfecting area within the SDTS such that people, pets, items, and/or other objects are disinfected. The SDTS may collect biometric data such as body temperature. Collected data may be analyzed to identify conditions and/or generate recommendations by matching collected data to various condition profiles. The SDTS may allow telemedicine sessions, where a user may communicate with a practitioner or virtual practitioner.

Claims (13)

1. A device comprising:

an inner wall comprising a proximate side wall portion, a distal side wall portion, and a ceiling;

a floor, wherein a disinfecting area of the device is enclosed by the inner wall and the floor;

one or more motion detection sensors that detect a person within the disinfecting area of the device;

a biometric sensor that collects at least one measurement associated with the detected person, the at least one measurement including body temperature;

a dispenser that distributes sanitizing solution from the ceiling by converting a liquid sanitizing solution to a mist and distributing the mist throughout the disinfecting area when a person is detected within the disinfecting area; and

an exhaust fan that further distributes the mist throughout the disinfecting area and prevents the mist from escaping the disinfecting area by collecting the mist at the floor.

2. The device of claim 1 further comprising at least one user interface element that provides an indication that disinfection is complete.

3. The device of claim 1 further comprising an access controller associated with an access gate, wherein the access controller opens the access gate when the body temperature is below a specified threshold.

4. The device of claim 1 further comprising at least one camera that captures user identifying information, wherein the user identifying information is associated with a stored user profile, wherein the stored user profile comprises at least one previously-collected measurement.

5. The device of claim 1 further comprising a two-way communication interface that communicates with at least one practitioner device.

6. The device of claim 5 , wherein the two-way communication interface comprises a touchscreen.

7. The device of claim 1 , wherein the disinfecting area comprises an entrance and an exit allowing users to pass through the disinfecting area.

Assignments (3)
SECURITY INTEREST Recorded Jun 18, 2026
From: VIVERA PHARMACEUTICALS INC
To: CROMWELL CAPITAL HOLDINGS LLC
Reel/Frame 075005/0300 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S STATE OF REGISTRATION PREVIOUSLY RECORDED AT REEL: 54035 FRAME: 655. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 8, 2021
From: HATAMIAN, MEHDI; EDALAT, PAUL
To: VIVERA PHARMACEUTICALS INC.
Reel/Frame 057852/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2020
From: HATAMIAN, MEHDI; EDALAT, PAUL
To: VIVERA PHARMACEUTICALS INC.
Reel/Frame 054035/0655 →
Continuity (1)
Related Publication 20220111091A1 · Apr 14, 2022